Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A), a global leader in life sciences and diagnostics, announced today its participation in the American Association for Cancer Research Annual Meeting (AACR). At the meeting, which will take place from April 5 to 10, 2024, in San Diego, CA, Agilent will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions. Featured products and solutions that play a crucial role in advancing cancer re
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks